Antheia Stock

A synthetic biology company for next generation plant-inspired medicines

Sign up today and learn more about Antheia Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Antheia Stock

Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole-cell engineering —reconstructing complex molecules in yeast to bring to market next-generation plant-inspired medicines.

Funding History

March 2015$2.0M
May 2017$6.2M
October 2017$9.5M
September 2018$9.2M
June 2021$73.0M


CEO & Co-Founder

Christina Smolke

Co-Founder ,CSO & Scientist

Kristy Hawkins


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: